Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists

Joint Bone Spine. 2010 Dec;77(6):625-6. doi: 10.1016/j.jbspin.2010.08.004. Epub 2010 Sep 20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / therapeutic use*
  • Blood Sedimentation
  • Crohn Disease / complications
  • Crohn Disease / drug therapy*
  • Crohn Disease / genetics
  • Drug Tolerance
  • HLA-B27 Antigen / classification
  • HLA-B27 Antigen / genetics
  • Humans
  • Joints / pathology
  • Joints / physiopathology
  • Male
  • Psoriasis / complications
  • Psoriasis / drug therapy
  • Psoriasis / genetics
  • Range of Motion, Articular
  • Severity of Illness Index
  • Spondylitis, Ankylosing / complications
  • Spondylitis, Ankylosing / drug therapy*
  • Spondylitis, Ankylosing / genetics
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Uveitis / complications
  • Uveitis / drug therapy
  • Uveitis / genetics

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • HLA-B27 Antigen
  • Tumor Necrosis Factor-alpha
  • tocilizumab